Clinical trial
A Phase 1 Trial of CV301 in Combination With Anti- PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
NCT02840994 is registered in ClinicalTrials.gov with Bavarian Nordic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Trial of CV301 in Combination With Anti- PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
- Lead sponsor
- Bavarian Nordic
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- January 31, 2020
- Enrollment
- 24 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer (nsclc)